Načítá se...
CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver
Human cytochrome P450 (CYP) 2C enzymes metabolize ∼30% of clinically prescribed drugs and various environmental chemicals. CYP2C8, an important member of this subfamily, metabolizes the anticancer drug paclitaxel, certain antidiabetic drugs, and endogenous substrates, including arachidonic acid, to...
Uloženo v:
| Vydáno v: | Mol Pharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society for Pharmacology and Experimental Therapeutics
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4702104/ https://ncbi.nlm.nih.gov/pubmed/26467040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.115.100255 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|